Safety study of LX22001 injection in healthy adults
Treatments studied
This study tests a new injection called LX22001 in healthy volunteers to see how it is processed in the body and if it is safe. It is a first-in-human trial, so you must be in good health and meet specific age, weight, and lifestyle requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy Chinese adult between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26. For example, if you weigh 65 kg and are 1.7 m tall, your BMI is about 22.5.
- Men must weigh at least 50 kg (110 lbs) and women at least 45 kg (99 lbs).
- You have no major medical conditions, allergies to study drugs, or recent surgeries that affect digestion.
- You do not smoke more than 5 cigarettes a day, drink heavily, or use recreational drugs.
- You have not taken any medications (including vitamins or herbal supplements) in the past month, and you agree to use effective contraception if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
This trial tests a new injection called GR2301 to see if it is safe in healthy people. Volunteers will help researchers understand any side effects before the drug is given to patients with a disease.
This is an early-stage study testing a new medicine called GR2301 given as multiple injections. Researchers want to see how safe it is and how the body handles it in healthy volunteers with no serious medical conditions.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.